Novel silk fibroin/elastin wound dressings by Vasconcelos, Andreia et al.
Acta Biomaterialia 8 (2012) 3049–3060Contents lists available at SciVerse ScienceDirect
Acta Biomaterialia
journal homepage: www.elsevier .com/locate /actabiomatNovel silk ﬁbroin/elastin wound dressings
Andreia Vasconcelos a, Andreia C. Gomes b, Artur Cavaco-Paulo a,⇑
aUniversidade do Minho, Departamento de Engenharia Têxtil, Campus de Azurém, 4800-058 Guimarães, Portugal
bCentre of Molecular and Environmental Biology (CBMA), Department of Biology, Campus de Gualtar, 4710-057 Braga, Portugal
a r t i c l e i n f o a b s t r a c tArticle history:
Received 28 October 2011
Received in revised form 12 April 2012
Accepted 20 April 2012
Available online 27 April 2012
Keywords:
Silk ﬁbroin
Elastin
Scaffold
Wound dressing
Wound healing1742-7061/$ - see front matter  2012 Acta Material
http://dx.doi.org/10.1016/j.actbio.2012.04.035
⇑ Corresponding author. Tel.: +351 2535 10100; fax
E-mail address: artur@det.uminho.pt (A. Cavaco-PSilk ﬁbroin (SF) and elastin (EL) scaffolds were successfully produced for the ﬁrst time for the treatment
of burn wounds. The self-assembly properties of SF, together with the excellent chemical and mechanical
stability and biocompatibility, were combined with elastin protein to produce scaffolds with the ability to
mimic the extracellular matrix (ECM). Porous scaffolds were obtained by lyophilization and were further
crosslinked with genipin (GE). Genipin crosslinking induces the conformational transition from random
coil to b-sheet of SF chains, yielding scaffolds with smaller pore size and reduced swelling ratios,
degradation and release rates. All results indicated that the composition of the scaffolds had a signiﬁcant
effect on their physical properties, and that can easily be tuned to obtain scaffolds suitable for biological
applications. Wound healing was assessed through the use of human full-thickness skin equivalents (Epi-
dermFT). Standardized burn wounds were induced by a cautery and the best re-epithelialization and the
fastest wound closure was obtained in wounds treated with 50SF scaffolds; these contain the highest
amount of elastin after 6 days of healing in comparison with other dressings and controls. The cytocom-
patibility demonstrated with human skin ﬁbroblasts together with the healing improvement make these
SF/EL scaffolds suitable for wound dressing applications.
 2012 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.1. Introduction
Skin wounds are the disruption of normal skin physiology. From
the moment the wound is created, the healing mechanism is initi-
ated to re-establish skin continuity. The healing process is complex
and involves an integrate response of different cell types and
growth factors [1–5]. Promotion of healing is often accompanied
by the use of biocompatible wound dressings: these should pro-
mote a moist environment in the wound and serve as a shield
against external factors like dust and bacteria; enhance water
and vapor permeation and promote epithelialization by releasing
biological agents to the wounds. Due to its unique properties of
high mechanical strength and excellent biocompatibility, silk
ﬁbroin has been explored for the development of wound dressings.
The degradation rates of electrospun silk materials applied as
wound dressings have been evaluated [6] and the incorporation
of growth factors into electrospun silk mats has been shown to
accelerate wound healing [7]. Moreover, silk ﬁlms have been
shown to heal full thickness skin wounds in rats faster than tradi-
tional porcine-based wound dressings [8].
Blending silk ﬁbroin with other components has been shown to
improve the properties of the resulting material. This allows the
modulation of biodegradation and release rates, importantia Inc. Published by Elsevier Ltd. A
: +351 2535 10293.
aulo).parameters in the biomaterials ﬁeld. Recently, we developed silk
ﬁbroin/keratin ﬁlms incorporating a synthetic inhibitor of elastase,
to control the high levels of this enzyme produced in a chronic
wound environment [9]. Silk ﬁbroin/alginate sponges demonstrate
a higher healing effect than both components acting alone [10]. In
this work, scaffolds based on silk ﬁbroin and soluble elastin were
developed and tested.
Elastin (EL) is an insoluble extracellular matrix protein that
provides elasticity and resilience to the arteries, lungs and skin
[11–13]. Due to its highly crosslinked nature, elastin is highly
insoluble and difﬁcult to process into new biomaterials. As a con-
sequence, soluble forms of elastin including tropoelastin [14],
a-elastin [15,16] and elastin-like polypeptides [17–19] are fre-
quently used to develop elastin-based biomaterials. Nevertheless,
a crosslinking step is required to obtain an insoluble material.
There are several crosslinking methods for elastin including chem-
ical [14,15,20], enzymatic [21], physical [16,22–24] and c-irradia-
tion [25]. Among them, chemical crosslinking agents are widely
used. Aldehydes and epoxy compounds have been commonly used
in biomaterial constructs due to their efﬁcient formation of cross-
links with amino acid side chains, low antigenicity and sufﬁcient
mechanical strength. Despite these advantages, they exhibit high
cytotoxicity [20,26,27].
Genipin (Ge) is a natural covalent crosslink agent isolated from
the fruits of Gardenia jasminoides Ellis [28] that offers comparable
crosslinking efﬁcacy. It has been reported that genipin binds withll rights reserved.
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matrices with goodmechanical properties, reduced swelling extent
and signiﬁcantly reduced cytotoxicity when compared to synthetic
crosslink agents like glutaraldehyde and epoxy compounds
[31,33].
To our knowledge, elastin has been crosslinked with collagen
[34,35], ﬁbrin [36,37] and gelatin [34,38] for the development of
biomaterials, but never with silk ﬁbroin. In this study, we devel-
oped silk ﬁbroin/elastin (SF/EL) scaffolds crosslinked with genipin.
The resulting materials were characterized by their physical–
chemical properties and the effect of crosslinking on those proper-
ties was evaluated. Moreover, the wound dressing functionality of
these materials was tested with a real chronic wound exudate and
the healing ability was assessed through the use of three-dimen-
sional (3-D) human skin equivalents.2. Materials and methods
2.1. Materials
Silk cocoons from Bombyx mori were kindly supplied from
‘‘Sezione Specializzata per la Bachicoltura’’ (Padova). Elastin solu-
ble from bovine neck ligament was purchased from Sigma (Spain).
Genipin is a product of Wako Chemicals (Germany). The BJ5ta cell
line (telomerase-immortalized human normal skin ﬁbroblasts)
was purchased from ATCC through LGC Standards.
Human full-thickness skin equivalents (EpidermFT) were sup-
plied by MatTek Corporation (USA). All other reagents, including
those used in cell culture, were analytical grade and purchased
from Sigma (Spain).2.2. Preparation of silk ﬁbroin solution
Silk was puriﬁed from its sericin content as previously de-
scribed [9,39–42]. The cocoons were cut, cleaned from debris and
larvae and autoclaved for 30 min at 120 C. Fibroin was then thor-
oughly washed with distilled water and dried overnight at room
temperature. Silk ﬁbroin (SF) solution (2% (w/v)) was prepared by
dissolving ﬁbroin in 9.6 M LiBr solution at 60 C for 3 h. The result-
ing solution was ﬁltered, and dialyzed against distilled water until
salts were completely removed, using cellulose tubing (Sigma,
Spain) (molecular-weight cut-off of 12,000–14,000 Da).2.3. Silk ﬁbroin/elastin blends preparation; crosslinking reaction;
scaffold formation
Elastin (EL) solution was prepared by dissolving the elastin
powder in distilled water. SF (2%) and EL (1%) were mixed to pre-
pare blends of 100/0 SF/EL, 80/20 SF/EL and 50/50 SF/EL. Genipin
(GE) powder, 0.1 and 0.5% (w/v) was added to blend solutions
under constant stirring at room temperature until complete disso-
lution of GE powder. The crosslinking reaction was carried out for
3, 6 and 24 h at 37 C. The resulting solutions were cast on 96-well
plates and frozen at 20 C for 2 days and freeze dried for 2 days to
remove the solvent completely. SF/EL scaffolds without genipin
were used as controls and were prepared by the same process de-
scribed above. The control samples were identiﬁed as 100SF, 80SF
and 50SF, which correspond to 0, 20 and 50% of elastin, and cross-
linked scaffolds were identiﬁed as 100SFyGE, 80SFyGE and
50SFyGE, where y is the genipin concentration used. In order to in-
duce the transition of SF from random coil to b-sheet structure and
consequently insolubility, scaffolds were immersed in 90% (v/v)
methanol solution for 30 min and then washed in distilled water
and air dried.2.4. Degree of crosslinking
The crosslinking degree was determined by the ninhydrin assay
[40–42]. Samples (6.0 ± 0.7 mg) were heated with a ninhydrin
solution (2% (w/v)) at 100 C for 20 min. The optical absorbance
of the resulting solution was recorded at a wavelength of 570 nm
using a Hekios c ThermoSpectronic spectrophotometer. The
amount of free amino groups in the test sample after heating with
ninhydrin is proportional to the optical absorbance of the solution.
The concentration of free NH2 groups in the sample was deter-
mined from a standard curve of glycine concentration vs. absor-
bance. SF/EL scaffolds prepared without genipin were used as
control materials. Triplicate samples were evaluated. The degree
of crosslinking was determined by the following equation:
Degreeof crosslinking ð%Þ ¼ ½ðNH2Þnc  ðNH2ÞcðNH2Þnc
 100 ð1Þ
(NH2)nc and (NH2)c are, respectively, the mole fraction of free
NH2 in non-crosslinked and crosslinked samples.2.5. FTIR spectroscopy
FTIR spectra of pure SF and SF/EL scaffolds were measured with
a Perkin-Elmer (Spectrum One FTIR) spectrometer in the spectral
region of 4000–650 cm1 with a ZnSe ATR cell. Spectra were ac-
quired for sponges with and without methanol treatment. For EL
samples, FTIR spectra were recorded in KBr pellets using a FTIR-
4100 from Jasco with a resolution of 2 cm1.2.6. Thermal analysis
Differential scanning calorimetry (DSC) measurements were
performed with a DSC-30 instrument (MettlerToledo), from room
temperature to 120 C, at a heating rate of 10 C min1, and kept
at 120 C for 10 min, to induce dehydration of samples. The tem-
perature was lowered to room temperature and increased to
500 C at a heating rate of 10 C min1. Sample weight was
2–3 mg. The open aluminum cell was swept with N2 during the
analysis. The analysis was performed in duplicate for scaffolds with
and without methanol treatment.2.7. Scanning electron microscopy (SEM)
Cross-sections were prepared by cutting the SF/EL scaffolds
with a razor blade in liquid nitrogen. Before analysis, the scaffolds
were coated with gold and examined morphologically using a
NOVA Nano SEM 200 FEI. The morphology was determined before
and after methanol treatment.2.8. Swelling ratio
SF/EL scaffolds, treated with methanol and completely dry
(60 C for 24 h) were immersed in phosphate-buffered saline
(PBS; pH 3.0, 7.4 and 11) at 37 C for 24 h. The excess buffer was
removed and the wet weight of the scaffolds was determined.
The swelling ratio of the ﬁlm was calculated as follows:
Swelling ratio ¼WS Wd
Wd
ð2Þ
WS is the mass of the swollen material and Wd is the initial dry
mass.
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The porosity of the SF/EL scaffolds with different blending ratios
was measured by the liquid displacement method [43]. Hexane
was used as the displacement liquid because it is a non-solvent
for SF. The scaffolds were immersed in a known volume (V1) of
hexane in a graduated cylinder for 30 min. The total volume of hex-
ane after impregnation into the scaffold was recorded as V2. The
impregnated scaffolds were then removed from the cylinder and
the residual hexane volume was recorded as V3. For all types of
scaffolds, experiments were carried out in triplicate. Data are
presented as average ± SD. One-way ANOVA analysis of variance
with Bonferroni post-tests was performed, with statistically signif-
icant differences when p < 0.001. All calculations were performed
using GraphPad software (version 5.03). The porosity of the scaf-
fold (e) was calculated by the following equation:
e ð%Þ ¼ V1  V3
V2  V3  100 ð3Þ2.10. In vitro degradation
2.10.1. Porcine pancreatic elastase (PPE)
SF/El scaffolds previously treated with methanol, with and
without crosslinking, were incubated for 21 days at 37 C in a solu-
tion containing 0.1 mg ml1 of PPE in 100 mM Tris–HCl buffer,
pH 8.0. The control samples were incubated in PBS buffer solution
(pH 7.4) without enzyme and submitted to the same conditions.
The solutions were replaced every 24 h.
2.10.2. Wound exudate
Wound exudate was collected from pressure wounds using a
vacuum assisted closure system. Wound ﬂuid was diluted ten-fold
in PBS solution and centrifuged to remove cells and tissue material.
SF/EL scaffolds were incubated with exudate in the same condi-
tions described above in a ﬁxed ratio of exudate per mg of scaffold
of 6 mg ml1. At designated time points, samples were washed
thoroughly with distilled water, dried in a desiccator and weighted
to estimate the extent of degradation by the following equation:
Weight loss ð%Þ ¼ m0 mf
m0
 100 ð4Þ
m0 and mf are respectively, the initial and ﬁnal dry mass of the
scaffold.
2.11. In vitro release
The release of a compound from SF/EL scaffolds was examined
by the incorporation of an antibacterial agent, gentamicin
(2 mg ml1). For control samples, gentamicin was dissolved in
the protein solutions and stirred for 5 min at room temperature.
The resulting solutions were cast in 96-well plates to prepare the
SF/EL scaffolds. In the case of crosslinked samples, gentamicin
was dissolved in the protein solution before crosslinking reaction.
Before release studies, control and crosslinked scaffolds were trea-
ted with methanol. SF/EL scaffolds were incubated at 37 C in PBS
buffer and in a solution containing 0.1 mg ml1 of PPE. Solutions
were changed every 24 h. At determined time points, aliquots were
taken and gentamicin release was determined using the o-phthal-
dialdehyde method [44]. The analysis was carried out by measur-
ing the maximum ﬂuorescence of gentamicin-o-phthaldialdehyde
complex using a multiplate reader (Synergy HT W/TRF from Bio-
Tek) in the ﬂuorescence mode at an emission wavelength of
456 nm. After each measurement, the samples were added back
to the medium to restore the equilibrium conditions. The quantiﬁ-
cation of the release was established by a gentamicin standardcurve. Release studies were performed in triplicate samples and
for a period of 7 days. The release behavior of compounds from
polymeric systems can be determined by ﬁtting the release data
to the empirical relationship given by the Ritger–Peppas equation
[45]:
Mt
M1
¼ ktn ð5Þ
Mt/M1 is the fractional drug release at time t; t is the release
time; k is the kinetic constant that measures the drug release rate,
and n is the diffusion exponent that depends on the release mech-
anism and the geometry of the matrix. To determine n values, Eq.
(4) is modiﬁed in Eq. (5) and n is determined from the slope of the
plot of log (%released) vs. log t.
log ð%releasedÞ ¼ logðMt=M1Þ ¼ log kþ n log t ð6Þ2.12. Cytotoxicity
The scaffolds were tested for cytotoxicity according to ISO stan-
dards (10993-5, 2009). The BJ5ta cell line (normal human skin
ﬁbroblasts) was maintained according to ATCC recommendations
(four parts Dulbecco’s modiﬁed Eagle’s medium (DMEM) contain-
ing 4 mM L-glutamine, 4.5 g l1 glucose, 1.5 g l1 sodium bicarbon-
ate, and one part of Medium 199, supplemented with 10% (v/v) of
fetal bovine serum (FBS), 1% (v/v) of penicillin/streptomycin solu-
tion and 10 lg ml1 hygromycin B). The cells were maintained at
37 C in a humidiﬁed atmosphere of 5% CO2. Culture medium
was refreshed every 2 to 3 days.
2.12.1. Test by indirect contact
Scaffolds (£=3 mm and 6 mm thickness) were sterilized by
immersion in ethanol 70% for 30 min, then hydrated and thor-
oughly rinsed with PBS. The conditioned media were obtained by
incubating the sponges in 1 ml of DMEM in a CO2 incubator at
37 C for 5 days. The sponges were then removed and the condi-
tioned media were obtained. Before use, the conditioned media
were ﬁltered to remove degraded scaffolds and diluted if necessary
in complete cell culture medium. Complete cell culture medium
subjected to the same conditions but not exposed to the sponges
was used as a negative control, whereas a 1% (v/v) solution of Tri-
ton X-100 (Sigma) prepared in fresh culture medium was used as
a toxicity positive control. Cells were seeded at a density of
20  103 cells/100 ll/well on 96-well tissue culture polystyrene
(TCPS) plates (TPP, Switzerland) the day before experiments and
then incubated with the conditioned media. At each deﬁned time
point (24, 48 and 72 h), cell viability was assessed using the Alamar
Blue assay (alamarBlue Cell Viability Reagent, Invitrogen). Resa-
zurin, the active ingredient of alamarBlue reagent, is a non-toxic,
cell-permeable compound that is blue in color and reduced to
resoruﬁn, red color compound, by viable cells. The quantity of
resofurin formed is directly proportional to the number of viable
cells. 10 ll of alamarBlue reagent was added to each well contain-
ing 100 ll of culture medium. After 4 h of incubation at 37 C the
absorbance at 570 nm was measured, using 600 nm as a reference
wavelength, in a microplate reader (Spectramax 340PC). Data are
presented as average ± SD of two independent measurements.
Two-way ANOVA with Bonferroni post-tests was performed, with
statistically signiﬁcant differences when p < 0.001. All calculations
were performed using GraphPad software (version 5.03).
2.12.2. Cell proliferation
Cell proliferation was determined in terms of DNA content to
monitor the effect of the scaffolds on ﬁbroblast. Scaffolds, prepared
and sterilized as previously described (£=15 mm and 3 mm
thickness), were gently placed in 24-well (TCPS) plates (TPP,
Table 1
Degree of crosslinking obtained for SF/EL solutions, for the different reaction
conditions, determined by Eq. (1).
Crosslinking treatment Degree of crosslinking (%)
100SF 80/20 SF/EL 50/50 SF/EL
3 h; 0.1% GE 15.2 ± 1.1 18.4 ± 1.5 22.6 ± 2.1
6 h; 0.1% GE 22.1 ± 1.3 29.3 ± 1.1 31.7 ± 1.8
24 h; 0.1% GE 23.5 ± 2.1 30.2 ± 1.5 29.8 ± 2.5
3 h; 0.5% GE 20.3 ± 1.9 24.2 ± 1.1 27.3 ± 2.1
6 h; 0.5% GE 28.6 ± 1.4 48.3 ± 2.2 52.2 ± 1.6
24 h; 0.5% GE 29.4 ± 1.6 46.7 ± 1.3 50.6 ± 2.2
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was loaded onto an upper side of each scaffold and allowed to inﬁl-
trate into the scaffold. The scaffolds were then incubated at 37 C
under 5% CO2 conditions for 3 h to allow for initial cell attachment.
After the initial incubation period the wells were then ﬁlled with
250 ll of medium and placed into a cell culture incubator and
maintained at 37 C with 5% CO2 for either 3 or 5 days. Culture
media were renewed every 2 days. After each indicated time inter-
val, cells/scaffold constructs were collected, rinsed with PBS and
cell proliferation was determined in terms of DNA content mea-
sured with Hoechst 33258 (Invitrogen). Brieﬂy, cells were har-
vested from cell-scaffold constructs by incubating with a 0.25%
solution of trypsin. Cells were then collected by centrifugation
and lysed in a Tris–HCl 15 mM pH 7.4 buffer with consecutive
freeze–thaw cycles. Cell lysates were incubated with equal volume
of 5 lg ml1 Hoechest 33258 solution for 40 min at room temper-
ature in the dark. Fluorescence was determined using a FLUOROS-
KAN ASCENT FL plate reader (ThermoScientiﬁc) at 350 nm
excitation and 445 nm emission. The relative ﬂuorescence unit
value obtained from samples was interpolated against a DNA stan-
dard curve constructed using known number of cells, to determine
the DNA content/number of cells in each sample. Data are
presented as average ± SD of two independent measurements.
Two-way ANOVA with Bonferroni post-tests was performed, with
statistically signiﬁcant differences when p < 0.001. All calculations
were performed using GraphPad software (version 5.03).2.13. Wound healing assay
Skin equivalents (EpidermFT) were cultured at the air–liquid
interface in tissue culture inserts placed in six-well plates accord-
ing to manufacturer’s instructions. Upon receipt the tissues were
placed into new six-well plates containing 2.5 ml of fresh culture
medium, supplied with the skin equivalents, and kept at 37 C,
5% CO2 overnight. Burn wounds were made by placing a cautery
on top of the tissue for 10 s. The SF/EL scaffolds were then placed
over the wounded area. Two burn wounds per tissue were made
to control wound size, and the healing was evaluated in two inde-
pendent assays. Skin equivalents without dressing and treated
with a commercial collagen dressing, Suprasorb C (Lohmann &
Rauscher, Germany), were used as controls.
Healing of these wounds was evaluated after 6 days by histolog-
ical evaluation. Skin equivalents were ﬁxed in 4% formaldehyde
solution at room temperature. Subsequently, parafﬁn-embedded
tissues section of 4 lm thickness were obtained and stained with
Haematoxylin and Eosin (H&E). All sections were observed under
a light inverted microscope (Olympus IX71).3. Results and discussion
3.1. Biochemical and biophysical properties of SF/EL scaffolds
The formation of covalent bonds on blended systems may pro-
duce stable and ordered materials with beneﬁcial effect on their
properties. To achieve such effect, genipin was used to crosslink
SF/EL scaffolds. Different crosslinking conditions were tested
(Table 1). After 3 h of reaction a color change in the solutions is ob-
served from light yellow to light blue, indicating the reaction be-
tween both SF and elastin with genipin. It is described that
genipin reacts with amino acids or proteins to form dark blue
pigments associated with the oxygen-radical polymerization of
genipin [30,32,46]. After 6 h of reaction, the solutions became dark
blue and the maximum crosslinking degree was reached.
The exact mechanism behind the interaction of genipin with
both SF and elastin is yet to be fully described. The generallyaccepted mechanism is similar to that observed for amino-group
containing compounds [32,47] where the ester groups of genipin
interact with the amino groups of SF and elastin, leading to the for-
mation of secondary amide linkages. Moreover, the amino groups
initiate nucleophilic attacks which result in the opening of the
genipin dihydropyran ring. An inherent phenomenon of genipin
crosslinking is self-polymerization, which occurs by radical reac-
tion of two amino-attached open rings [47,48]. Some authors
[46] reported that genipin preferentially reacts with the amino
acids lysine and arginine. SF and elastin contain respectively,
0.95% and 1.07% of these amino acids, which is a very low fraction.
The crosslinking sites are thus low in number, which results in
lower crosslinking degrees when compared with other genipin
crosslinked blend systems [49]. The highest crosslinking degree
obtained for sponges containing elastin might be related with the
slightly higher fraction of lysine and arginine amino acids.
The genipin crosslinking of SF/EL scaffolds might induce confor-
mational changes due to the structural rearrangement of chains to
form covalent bonds. FTIR spectra of SF and elastin, with and with-
out crosslinking, in the range of 600–2000 cm1 are represented on
Fig. 1. SF protein exists in three conformations namely random coil,
Silk I (a-form) and Silk II (b-sheet conformation). The 100SF spec-
trum (Fig. 1a) show bands at 1640 cm1 for amide I (C@O stretch-
ing), 1517 cm1 with a shoulder at 1532 cm1 for amide II (N–H
deformation) and 1238 cm1 for amide III (C–N stretching, C@O
bending vibration), indicating a random coil/Silk I conformation
[50–53]. SF molecules can structurally rearrange due to changes
in the hydrogen bonding by methanol treatment acquiring a
b-sheet conformation. Genipin crosslinking is also able to induce
b-sheet conformation of SF molecules. Comparing the SF spectra
obtained after genipin crosslinking, it is clearly the transition from
random coil to b-sheet conformation conﬁrmed by the shifting to
lower wavenumbers of amide I (1620 cm1) and amide II
(1514 cm1) bands [50–53]. The shoulder observed at 1532 cm1
for amide II assigned to random coil, progressively disappears with
the increase in genipin concentration. Moreover, a characteristic
band of genipin at 1105 cm1 (–COH) appeared in the spectra of
100SF0.1GE and 100SF0.5GE, conﬁrming once again the reaction
between genipin and SF. The FTIR results evidenced that genipin
crosslinking of SF is followed by protein conformational changes
already shown by other authors [42,49]. Fig. 1b shows the spec-
trum for elastin protein that was acquired in powder form using
KBr pellets. 100EL spectrum shows characteristic protein bands
at 1651 (amide I), 1537 (amide II) and 1239 cm1 (amide III), as-
signed to random coil conformation [54–56]. It can be seen that
genipin induces in elastin structural changes into a more b-sheet
conformation. This was conﬁrmed by the shifting to lower wave-
numbers of the amide I band. In addition, the appearance of a
new peak at 1104 cm1 and 1113 cm1, characteristic of genipin,
conﬁrms the crosslinking reaction. The intensity of this peak is
directly proportional to the amount of genipin used for the cross-
linking. The results obtained after methanol treatment of the
Fig. 1. FTIR absorbance spectra (a) of pure silk ﬁbroin (100SF) and (b) pure elastin
(100EL) and crosslinked with genipin (100X0.1GE and 100X0.5GE, where X is SF or
EL). Fig. 2. DSC scans of (a) pure silk ﬁbroin (100SF) and (b) pure elastin (100EL) and
crosslinked with genipin (100X0.1GE and 100X0.5GE, where X is SF or EL).
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proteins, when compared with genipin crosslinked spectra.
FTIR spectra of blend systems show slightly changes of the
wavenumbers and on the areas of the bands due to mixing effects
of SF with elastin. The areas under the peaks for pure and blend
systems were calculated by integration, and the ratio AN–H (area
of N–H bending, amide II) to AC@O (area of C@O stretching, amide
I) (data not shown). It was shown that the addition of elastin
decrease the ratio of AN–H/AC@O. Moreover, the area of C–O–C,
attributed to genipin, increases along with the ratio AN–H/AC@O
due to the carboxyl group from genipin. This fact is evidence of
the crosslinking reaction. The higher decrease in the ratio AN–H/
AC@O obtained for the blend systems is the combined effect of addi-
tion of elastin and genipin crosslinking.
The interaction between SF and elastin, crosslinked with geni-
pin, was further investigated using thermal analysis (DSC). DSC
scans for SF and elastin are shown in Fig. 2a and b respectively.
The DSC curve for 100SF shows an endothermic shift at 184 C that
corresponds to the glass transition temperature (Tg) of SF. This
value is in the range of others previously reported for SF with a
random coil conformation [39,57]. The exothermic peak at 226 C
is related to the crystallization of amorphous SF chains caused by
the transition to b-sheet structure [52,56,58]. The DSC curve of
SF is also characterized by an intense endothermic peak at 284 C
(Td) related to the decomposition of SF chains.The thermal behavior of 100SF is typical of an amorphous SF
with random coil conformation as previously shown by FTIR re-
sults. Addition of genipin induces a small decrease in the Tg and
an increase in the decomposition temperature. The increase in
the thermal stability, given by the increase in Td, of 100SF scaffold
containing genipin is due to the increase in the extent of covalent
crosslinks. This fact is the conﬁrmation of the crosslinking reaction
between genipin and SF. Furthermore, the exothermic peak at
226 C shifts to lower temperature (100SF0.1GE) and disappears
for the sample 100SF0.5GE. This result shows once again the
change in the SF conformation from random coil to b-sheet after
genipin crosslinking, and how this change is affected by the con-
centration of crosslinking agent.
The DSC curve of elastin (Fig. 2b) shows an endothermic shift at
197 C assigned to the glass transition temperature of soluble
elastin peptides [59]. The thermogram is further characterized by
a weak and broad endothermic peak at 265 C, related to the
decomposition of small aggregated structures and a more intense
endothermic peak at 320 C related to a component decomposition
at high temperature. Addition of genipin caused the decrease in the
Tg and, although it was not observed, an increase in the decompo-
sition temperature (320 C); the weak peak at 265 C progressively
disappears with the addition of genipin. This fact indicates that the
small aggregates disappeared due to the crosslinking reaction be-
tween genipin and elastin. In the blend system (data not shown)
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suggesting once again the crosslinking effect. Nevertheless, the in-
crease in Td is not dependent on blend composition because blends
with higher crosslinking degree will not have higher thermal
stability.
The 3-D morphology of the SF/EL scaffolds was analyzed by
SEM. The images presented are related to control and crosslinked
scaffolds without methanol treatment. The 100SF sample
(Fig. 3a) shows a disordered pore-like structure with a rough sur-
face. The pores are interconnected by a number of even smaller
pores. Addition of elastin creates a more open and loose structure
with thinner walls (Fig. 3b and c). In the case of 50SF (Fig. 3c) a ﬁbr-
ilar structure can be observed. The presence of large pores in the
scaffolds facilitates cellular inﬁltration and growth within the
3-D structure [16,60]. However, such a loose network will have
detrimental effects on mechanical, swelling and release properties.
To overcome this, genipin crosslinking was performed and the
results clearly evidenced that genipin changes the scaffold mor-
phology. 100SF0.5GE scaffold (Fig. 3d) shows a more ordered pore
structure interconnected between sheets, characteristic of a
b-sheet conformation [58,61]. In addition, the SEM images ob-
tained after methanol treatment (data not shown) show the same
morphology observed with genipin crosslinking. This result showsFig. 3. (A) SEM images of SF/EL scaffolds without genipin: (a) 100SF, (b) 80SF and (c) 50
Porosity percentage of SF/EL scaffolds. Each column represents the average ± SD (n = 3) (s
and ⁄⁄⁄p < 0.001).the interaction between genipin and SF with conformational
changes that are patent of the scaffold morphology already con-
ﬁrmed by FTIR and DSC results. In the blended system, it can be
seen that the loose network obtained upon addition of elastin
becomes more closed and compact due to genipin crosslinking.
The ﬁbrils observed in 50SF scaffold disappeared after crosslinking,
originating thicker walls (Fig. 3f).
Porosity measurement of scaffolds was done by the liquid dis-
placement method, using hexane as a displacement liquid. Hexane
was used because it permeates easily through the interconnected
scaffold pores, causing negligible swelling or shrinkage. Porosity
determination is important in tissue engineering as a highly porous
structure provides much surface area that promotes better cell
growth through the easer passage of nutrients to the growing cells.
All the scaffolds, without genipin crosslinking, showed porosity
ranging between 100 and 70%, as shown in Fig. 3B. Addition of
elastin increases the porosity of the scaffolds as can be seen by
SEM analysis (Fig. 3A). Crosslinking with genipin signiﬁcantly
(p < 0.001) decreases the porosity of the SF/EL scaffolds, and the
porosity increases accordingly to the elastin content in the scaffold.
Water-binding of scaffolds is an important parameter of
biomaterials properties. To study the swelling ratio in response
to external pH conditions, SF/EL scaffolds were immersed in PBSSF; after genipin crosslinking: (d) 100SF0.5GE, (e) 80SF0.5GE and (f) 50SF0.5GE. (B)
igniﬁcant differences between non-crosslinked and crosslinked samples at ⁄⁄p < 0.01
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are presented in Fig. 4. The swelling ratio of SF/EL scaffolds was
lower in acidic conditions and became progressively higher at neu-
tral and alkaline media. The lowest swelling ratio obtained at pH 3
might be attributed to the formation of hydrogen bonds between
SF and elastin due to the presence of carboxylic acid groups
(–COOH) and hydroxyl groups (–OH). Increasing the pH, the car-
boxylic acid groups became ionized (–COO) and consequently,
higher swelling ratios are observed due to a higher swelling force
induced by the electrostatic repulsion between the ionized acid
groups.
The swelling ratio was found to be dependent on the composi-
tion; 50SF scaffolds, with and without genipin, showed maximums
swelling ratios (Fig. 4). SEM analysis (Fig. 3c) indicates that 50SF
samples presented larger pores with a loose network, still observed
after crosslinking, which results in a higher hydrodynamic free
volume to accommodate more of the solvent molecules, thus
increasing scaffold swelling [62,63].
Crosslinking with genipin also affects the swelling ratio of the
scaffolds. Increasing genipin concentration leads to a decrease in
the swelling ratios. Generally, the swelling behavior of the scaf-
folds can be controlled by its composition and crosslinking degree.
In the SF/EL scaffolds, genipin crosslinking created stable struc-
tures that hinder the mobility and relaxation of the macromolecu-
lar chains, lowering the swelling ratio due to water restrict
mobility [64]. This effect is more pronounced in 80SF and 50SF
scaffolds that attained higher crosslinking degrees when compared
with 100SF. The decrease in the swelling ratio can also beFig. 4. The pH-dependent swelling ration of 100SF (a) 80SF, (b) and 50SF (c) scaffocorrelated with the scaffold compact structures formed after cross-
linking (Fig. 3d–f).
3.2. In vitro and ex vivo biological degradation
Degradation rate of matrices plays an essential role in the deter-
mination of the release of entrapped bioactive agents. The in vitro
degradation of SF/EL scaffolds was investigated by incubation in a
isotonic, physiological pH solution (PBS, pH 7.4) and a protease rich
medium (PPE and human exudate from chronic wounds) at 37 C
for several days. At determined time points, samples were removed
and washed with distilled water, dried and weighed to determine
the extent of degradation using Eq. (4). The results are presented in
Fig. 5. Scaffolds incubated with PBS solution showed almost no
degradation within 21 days. From the results it can be seen that
the degradation is dependent on scaffold composition. Higher
weight loss was obtained for samples containing higher amounts
of elastin. After 21 days of incubation, the weight loss obtained
for 100SF, 80SF and 50SF in PPE solution was 26, 36 and 49%
respectively. The low weight loss obtained for 100SF is related to
the crystallinity of ﬁbroin due to the presence of b-sheet struc-
tures. Therefore, the observed weight loss is probably due to the
degradation of the small hydrolytically peptide sequences that
remain after scaffold crystallization [65]. Nevertheless, this effect
is minimized after genipin crosslinking that increases the b-sheet
content, creating a closed and compact scaffold network (Fig. 3d).
This will diminish the diffusion of solution within the scaffold,
increasing the resistance to protease degradation. The higherlds after 24 h of immersion in buffer solutions at 37 C determined by Eq. (2).
Fig. 5. In vitro degradation of SF/EL scaffolds incubated with 0.1 mg ml1 of PPE and
wound exudate (2.4 lg ml1 of total protein content) at 37 C for 21 days. Fig. 6. Cumulative release of gentamicin from SF/EL scaffolds incubated with
0.1 mg ml1 of PPE at 37 C for 21 days.
Table 2
Model compound release kinetic data obtained from ﬁtting the experimental release
data to Eq. (6).
Sample Kinetic parameters
n k R2
100SF 0.579 0.954 0.991
80SF 0.471 1.119 0.994
50SF 0.415 1.204 0.991
100SF0.5GE 0.551 0.813 0.998
80SF0.5GE 0.451 1.016 0.990
50SF0.5GE 0.418 1.159 0.990
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elastin is a substrate for elastase. In the human body, elastin, one
of the major components of connective tissues, is degraded by
human leukocyte elastase (HLE) [66–68]. In this way, SF/EL scaf-
folds might be used as elastase-speciﬁc wound dressings for
chronic wounds. Moreover, it has already been demonstrated that
elastin-based dressings promote a better wound healing either by
an improvement of ﬁbroblasts adhesion and proliferation [16,60]
or by the reduction of wound contraction [69,70].
The loose network observed for scaffolds containing elastin
(Fig. 3c) is also responsible for the higher weight loss obtained
due to the increase in the surface area. As observed before, the gen-
ipin crosslinking decreases the weight loss observed. The creation
of a more compact structure between SF and elastin hinders scaf-
folds degradation. These results show that genipin crosslinking
was effective in the control of degradation.
The results obtained with wound exudate show the same deg-
radation pattern but with higher values. The exudate solution used
for incubation was less concentrated than PPE solution
(2.4 lg ml1 of total protein content). Nevertheless, the wound
exudate is a mixture of several proteases, including HLE, that act
synergistically, increasing the hydrolysis.3.3. In vitro release
The effect of scaffold composition and genipin crosslinking on
the release of model compounds was investigated. The release
behavior of gentamicin from SF/EL scaffolds in PPE solution is
shown in Fig. 6. The release of this compound was monitored in
PBS solution (data not shown) and the release observed was low.
Gentamicin has been used topically in the treatment of superﬁcial
infections of the skin since it is effective against many aerobic
Gram-negative and some aerobic Gram-positive bacteria. In this
way, the antibacterial properties of SF/EL scaffolds will also be
exploited. The release proﬁle shown can be divided into three
parts: an initial burst release in the initial 24 h, due to the release
of the compound bound to the surface of the scaffold; a continuous
phase release from 24 to 72 h; and a stagnant phase release for the
remaining period of time. Furthermore, it was observed that higher
release was obtained for scaffolds containing higher amounts of
elastin. The release of a compound from a matrix is governed by
several factors such as nature and size of the compound, degree
and density of crosslinking and pore size among others. From the
SEM results discussed previously, it was concluded that higher
elastin content leads to scaffolds with higher pore size which inturn cause the release of higher amounts of compounds. Genipin
crosslinking induces slower release rates (Fig. 6). This is attributed
to the fact that genipin crosslinking enhances the decrease of pore
size. In this way, the diffusion of the compounds through the
scaffold pores is more difﬁcult and lower release is attained.
To determine the release mechanism present in the SF/EL scaf-
folds, the experimental data were ﬁtted to the semi-empirical
power law model [71,72] given by the Ritger–Peppas equation
(Eq. (5)). This equation is further modiﬁed to determine the diffu-
sional exponent, n (Eq. (6)) that depends on the release mechanism
and the geometry of the matrix [45,71]. There are three different
mechanisms that can be concluded from the n value. Therefore,
the release, from a cylindrical geometry like the sponges devel-
oped, is purely Fickian diffusion when n = 0.45; for 0.45 < n > 0.89
anomalous (non-Fickian) transport is present and, for n = 0.89 the
release is dominated by Case II transport (matrix relaxation or
swelling-controlled mechanism).
The results in Table 2, for control samples without crosslinking,
showed that the release of gentamicin is dominated by anomalous
transport because n values are above and below 0.45. In the blends,
increasing elastin content, the values for release rate, k, became
progressively higher. This indicates that the addition of elastin im-
proves the release of drugs from the scaffolds probably due to the
increase in swelling ratio and degradation rate, for higher elastin
content as previously discussed. On the other hand, the decrease
in the values for diffusional exponent, n, closest to 0.45, suggests
that the addition of elastin also improves the diffusion of drugs
from the scaffolds.
Addition of genipin gradually changes the mechanism from
anomalous transport to Fickian diffusion, especially for the sample
80SF0.5GE (n = 0.451). Furthermore, the crosslinking effect on the
Fig. 7. Viability of human normal skin ﬁbroblasts after 24 h, 48 h and 72 h of
contact with conditioned medium (culture medium where scaffolds were incu-
bated). Only the positive control (treatment with Triton detergent) revealed
diminished cell viability. (⁄⁄⁄ = signiﬁcantly different from all the other tested
conditions, p < 0.001).
Fig. 8. Number of human normal skin ﬁbroblasts cells, determined in terms of DNA
content, after 3 and 5 days of direct contact (signiﬁcantly different from cells
control after 3 days of incubation at ⁄p < 0.05, ⁄⁄p < 0.01 and ⁄⁄⁄p < 0.001; signiﬁ-
cantly different from cells control after 5 days of incubation at #p < 0.05,
##p < 0.01and ###p < 0.001).
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pores) also inﬂuences the release rate. It is observed that the
release rate becomes slower (lower k values) for higher amounts
of elastin, due to the higher crosslinking degree obtained for these
samples as explained before. The release results clearly support the
notion that the release from SF/EL scaffolds is affected by its com-
position and that genipin crosslinking can be used to modulate the
release mechanism and rate of the compounds.
3.4. Cytocompatibility SF/EL scaffolds
Biocompatibility of SF/EL scaffolds, with and without genipin
crosslinking, was assessed in human skin ﬁbroblasts in in vitro cul-
tures. The results of the indirect contact study after ﬁbroblast incu-
bation with material extracts showed no cytotoxicity caused by
medium conditioned by the scaffolds regardless of the incubation
time. Fig. 7 represents the viability results for cells in contact with
undiluted conditioned media. In all cases, the metabolic activity of
cells in contact with the conditioned media was statistically similar
or higher than the one obtained with negative control (complete
culture medium). This result constitutes a preliminary study of
the biocompatibility of SF/EL sponges, indicating that these mate-
rials are not cytotoxic.
Direct contact study was performed by seeding the cells on the
scaffolds to evaluate the effect of SF/EL scaffolds on ﬁbroblasts pro-
liferation. The results presented in Fig. 8 showed a time-dependent
increase in the number of cells that may suggest an increase in cell
proliferation. Human skin ﬁbroblasts continued to increase in
number over the period examined, indicating that the scaffolds
are able to support ﬁbroblasts proliferation without producing
toxic effects. It can also be observed that the presence of elastin
on the scaffolds favors cell proliferation. Especially after 5 days of
incubation. This fact is explained by the increase of hydrophilicity
introduced by the presence of elastin that enhances cell adhesion
and subsequent activity. For scaffolds crosslinked with genipin a
decrease in the number of cells is observed when compared to
non-crosslinked scaffolds, which might be related with the de-
crease in the porosity caused by the genipin crosslinking that
inhibits cell inﬁltration.
Preliminary studies on the immunogenicity of SF/EL scaffolds
were performed in vitro by measuring TNFa production by
THP-1 human macrophages exposed to these materials (data not
shown). The results suggested that SF/EL scaffolds induceproduction of low levels of the inﬂammatory mediator TNFa by
these cells after 48 h of incubation when compared to PMA
(phorbol 12-myristate-13 acetate), which is known to differentiate
THP-1 cells into macrophage-like cells and mimic the intrinsic acti-
vation and differentiation signals that macrophages encounter dur-
ing the foreign body reaction [73]. This additional observation
further supports the notion that SF/EL scaffolds are non-immuno-
genic and represent a safe alternative biomaterial for the treatment
of wounds.3.5. Wound healing
To determine the effect of SF/EL scaffolds on the wound healing,
materials were applied on the top of the wound immediately after
causing the burn. Histological evaluation (Fig. 9) of the healing pro-
cess after a period of 6 days revealed that SF/EL scaffolds induced
ﬁbroblasts and keratinocytes proliferation and migration to the
wound site, especially for wounds treated with scaffolds contain-
ing elastin (Fig. 9a and b). The healing improvement obtained with
SF/EL scaffolds is similar to the commercial collagen dressing,
Suprasorb C, used in several types of wounds including burn
wounds.
Microscopic observations of the wounds indicated that the con-
trol sample (Fig. 9a) is characterized by the absence of epithelium
and the dermis is covered with crust from burning. After 6 days of
healing, the crust had disappeared from the control sample
(Fig. 9b) and from samples treated with different materials. In
addition, wounds treated with dressings (collagen and SF/EL scaf-
folds) induced keratinocyte and ﬁbroblast migration from the
margins to the wound ground, which should result in a faster re-
epithelialization and wound closure. Partial-thickness burn
wounds heal almost entirely by epithelialization from the skin
periphery to the wound core [74,75], which was also observed in
this study. For this reason, histological examination was done with
sections obtained in the center of the wound, so the results pre-
sented and the differences obtained are related with the healing
improvement by SF/EL scaffolds and not by natural artifacts. From
the histological results obtained it is also visible that wounds trea-
ted with scaffolds containing higher amounts of elastin (50SF;
Fig. 9f) are almost completely closed and covered with new epithe-
lium, which was not the case in controls. The results indicated that
Fig. 9. Histological analysis of burn wound tissues stained with H&E: (a) control wound (no dressing) immediately after burning; (b) control wound (no dressing) after 6 days
of healing; (c) wound treated with commercial collagen dressing, Suprasorb C, after 6 days of healing; (d) wound treated with 100SF scaffold after 6 days of healing; (e)
wound treated with 80SF scaffold after 6 days of healing; (f) wound treated with 50SF scaffold after 6 days of healing. Bars = 100 lm.
3058 A. Vasconcelos et al. / Acta Biomaterialia 8 (2012) 3049–3060wound size reduction was signiﬁcantly greater in the order of
50SF > 80SF > 100SF = Suprasorb C > No dressing.
The characterization results presented earlier indicated that
scaffolds containing higher amounts of elastin become more swel-
lable, ﬂexible and elastic. These characteristics suggest that the
attachment of the cells within the wound to the dressing is im-
proved, resulting in a faster re-epithelialization.
Elastin is the major constituent of skin elastic ﬁbers and is ben-
eﬁcial for dermal regeneration [76]. Several studies have explored
the application of elastin containing materials for wound healing,
such as scaffolds of collagen and solubilized elastin [77] or dermal
substitutes coated with elastin [69,78]. Silk ﬁbroin based-biomate-
rials have also been used in this ﬁeld with promising results
[7,8,10]; nevertheless, the present study exploits for the ﬁrst time
the combination of silk ﬁbroin and elastin for the production of
wound dressing scaffolds.4. Conclusion
Novel SF/EL scaffolds crosslinked with genipin were success-
fully obtained. The genipin crosslinking results in the conforma-
tional transition of SF chains from random coil to b-sheet
conformation. The SF/EL scaffolds presented different pore sizes
and distinct morphologies which are related with the elastin ratio
and genipin crosslinking. The biochemical and biophysical proper-
ties of the scaffolds such as higher thermal stability, pH-swelling
dependence and reduced biological degradation and drug release
rates were obtained after genipin crosslinking with a concentration
of 0.5%. A very important technical approach of this study was the
validation of SF/EL scaffolds using human wound exudates. Degra-
dation was evaluated using wound exudates, and it was observed
that genipin crosslinking reduces susceptibility to degradation in
this particular context. Moreover, SF/EL scaffolds showed no cyto-
toxicity and are able to support cell proliferation in vitro in human
skin ﬁbroblasts. Dermal burn healing experiments using human
skin equivalents have shown that the application of SF/EL scaffoldscontaining higher amount of elastin accelerates re-epithelializa-
tion and wound closure. The results presented are important in
the design and application of tailor-made biomaterials for wound
dressings.
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